Here's another great hire (sarcasm) HOUSTON, TX / ACCESSWIRE / July 5, 2018 / Oncolix, Inc. (ONCX) (the "Company"), a biotechnology company focused on gynecological cancers, announced that Andrew Scott has joined the Company as its Vice President of Corporate Development. "Andrew is a seasoned veteran that understands the important roles of Investor Relations , banking relationships and raising capital ," said Michael T. Redman, president and chief executive officer of Oncolix. Let's see how he's doing: Investor relations: ONCX now trading appx .01 after making new 52 week low of $0.0065 - Grade: FAILURE Banking Relationships: Appears ONCX hasnt developed any new banking relationships that have been disclosed. Grade: FAILURE Raising capital: Has ONCX raised any meaningful capital since this hire? Answer is NO!! Grade: FAILURE Keep up the good work ONCX management team!! At least you're meeting my expectations!!